Shots:

• The companies collaborated to discover fully human mAbs against multiple viruses with an initial focus on discovering Abs targeting SARS-CoV-2
• Abveris offers complete gene-to-Ab discovery services by combining advanced immunization methods with B cell screening and hybridoma-based Ab discovery technologies & its AI platform was used to identify highly conserved, immutable target sites on viruses
• The collaboration will use Enzolytics’ patient donor peripheral blood mononuclear cell (PBMC) samples and peptide screening tools to identify Ag-binding Abs & rapid B cell screening. The collaboration will also expand Enzolytics’ Ab portfolio

Ref: Accesswire| Image: Enzolytics